Child (3-12)

Clinical Study for Skin and Scalp Diseases in Individuals with Down Syndrome

This study is testing whether a medicine called abrocitinib can help people 12 years and older with Down syndrome treat alopecia areata (hairloss) and symptoms of atopic dermatitis (eczema).
Principal investigator
Emma Guttman, MD, PhD and Dusan Bogunovic, PhD
Location
New York, NY
Age range
12 years and older

Understanding Differences in Thinking, Learning, and Behavior for Individuals with Down Syndrome With and Without Childhood Cancer

The goal of this study is to learn about differences in thinking, learning, and behavior for individuals with Down syndrome with and without a history of childhood cancer; we are recruiting parents and caregivers of individuals with Down syndrome and no history of childhood cancer for this part of the study.
Principal investigator
Lisa Jacola, PhD, ABPP-CN Neuropsychologist, Associate Faculty Member
Location
Virtual
Age range
All ages

Parent Survey to Understand Challenging Behaviors in Down Syndrome (BIDS-Phase 2)

Caregivers of children and teenagers with Down syndrome ages 2 to 17 are invited to complete a survey helping develop the first-ever tool measuring challenging behavior that is specifically made FOR children with Down syndrome and created WITH the Down syndrome community.
Principal investigator
Anna Esbensen, PhD
Location
Virtual
Age range
2 to 17 years old